NurExone Biologic (TSXV: NRX) (Germany: J90) retweeted
Could exosomes help repair damaged nerves after spinal cord injury? Dr. Lior Shaltiel, CEO of NurExone Biologicsm (@NBiologic), discusses promising early research, challenges and the path to human trials.
Read more: xtalks.com/exosome-therap…
#ExosomeTherapy #RegenerativeMedicine
Read more: xtalks.com/exosome-therap…
#ExosomeTherapy #RegenerativeMedicine
0
1
1
159
globenewswire.com/news-release/2…
An MOU with Nanopass will allow evaluation of clinically established MicronJet™ technology with our exosome formulations for optic nerve and skincare applications.
ExoPTEN for acute spinal cord injury continues to advance separately on its existing path.
An MOU with Nanopass will allow evaluation of clinically established MicronJet™ technology with our exosome formulations for optic nerve and skincare applications.
ExoPTEN for acute spinal cord injury continues to advance separately on its existing path.
0
0
1
208
We announced our Q1 2026 financial results and corporate update.
Read the full announcement: globenewswire.com/news-release/2…
Read the full announcement: globenewswire.com/news-release/2…
0
0
2
104
What if paralysis 👨🦽 wasn’t permanent - or at least not untreatable?
What if we could deliver regenerative signals to the central nervous system… through a simple intranasal spray?
In our latest @ProgressPotent1 episode, @liorshal (CEO of @NBiologic) breaks down the - an exosome-based therapy designed to deliver siRNA and temporarily silence the PTEN signaling pathway, one of the nervous system’s key “brakes” on regeneration. 🚀
In preclinical models, this approach has shown something rarely seen in this field: meaningful functional recovery after severe spinal cord injury.
We explore:
- Why the central nervous system struggles to regenerate;
- Whether exosomes can finally solve the delivery problem;
- Dr. Shaltiel’s journey - from ion channel biophysics to leading one of the more ambitious bets in neuroregeneration;
#Biotech #Neuroscience #SpinalCordInjury #RegenerativeMedicine #Exosomes #Neuroregeneration #GeneSilencing #FutureOfMedicine #HealthTech #Longevity
@russopartners @HebrewU
0
0
1
122
Join us at the Water Tower Research LLC Insights Conference, a virtual event for investors seeking direct access to innovative companies.
Register here: lnkd.in/eE59ij_4
NurExone’s session will take place on Tuesday, April 14, at 11:50 AM EST.
Register here: lnkd.in/eE59ij_4
NurExone’s session will take place on Tuesday, April 14, at 11:50 AM EST.
0
1
1
84
Over the past year, the term "exosome" entered mainstream conversation, but much of the visibility came from cosmetic or plant-derived products. The next phase looks very different.
Do you agree that 2026 marks the shift to therapeutic reality for exosomes?
Do you agree that 2026 marks the shift to therapeutic reality for exosomes?
1
0
1
148
Welcoming Eyal Gabbai to our Board!
He brings a strong mix of patient perspective, health-system economics and capital markets experience to help translate strong science into real-world care.
Read more: globenewswire.com/news-release/2…
He brings a strong mix of patient perspective, health-system economics and capital markets experience to help translate strong science into real-world care.
Read more: globenewswire.com/news-release/2…
0
1
4
237
⚡ NurExone’s exosomes show significant anti-inflammatory activity, outperforming commercial alternatives in new laboratory analysis!
#Biotech #Exosomes #RegenerativeMedicine #Innovation #NurExone $NRX
Read here: lnkd.in/er_dyYRs
#Biotech #Exosomes #RegenerativeMedicine #Innovation #NurExone $NRX
Read here: lnkd.in/er_dyYRs
0
1
4
335
🗞️ Planning Small-Scale ExoPTEN Clinical Manufacturing in Preparation for Future First-in-Human Use Pathways!
#NurExone #ExoPTEN #Exosomes #Biomanufacturing #ClinicalReadiness
Read more: lnkd.in/dd9qjaCu
#NurExone #ExoPTEN #Exosomes #Biomanufacturing #ClinicalReadiness
Read more: lnkd.in/dd9qjaCu
0
0
2
225
We released our Q3 results and corporate updates on Friday, highlighting scientific progress, strengthened IP, and continued momentum toward clinical readiness.
Read more: lnkd.in/du39EqS8
Read more: lnkd.in/du39EqS8
0
0
1
154
NurExone was nominated for The Galien Foundation Best Bridge Builder Award as we bridge academic research and applied innovation.
#SeeyouinStockholm #GalienPrix #BridgeBuilding
prnewswire.com/news-releases/…
#SeeyouinStockholm #GalienPrix #BridgeBuilding
prnewswire.com/news-releases/…
0
1
1
140
NurExone Biologic is pioneering a class of regenerative medicines that harness the body's own communication system to develop therapies with the potential to regenerate, repair & restore nerve function!
#Exosomes #ExoTherapy #BiotechInvesting #SpinalCord
#Exosomes #ExoTherapy #BiotechInvesting #SpinalCord
0
1
5
257
The Jerusalem Post highlighted ScienceAbroad’s work connecting thousands of Israeli scientists worldwide, advancing collaboration, mentorship, and the global exchange of ideas.
Thank you Judy Siegel-Itzkovich for the wonderful coverage!
📖 Read here: jpost.com/science/articl…
Thank you Judy Siegel-Itzkovich for the wonderful coverage!
📖 Read here: jpost.com/science/articl…
0
0
2
107
Read more about NurExone's Regenerative Therapy for CNS injuries under development: advancingrna.com/doc/developing…
1
1
3
254